Chemotherapy-Induced Nausea and Vomiting: Emerging Therapies and New Guidelines
This activity is supported by an educational grant from Eisai, Inc.
Diagnosing and Treating Chemotherapy-Induced Nausea and Vomiting: Understanding the Need and Clinical Data for Best Patient Care
Hope S. Rugo, MDProfessor of MedicineDirector, Breast Oncology Clinical Trials EducationDepartment of Medicine, Division of Hematology/OncologyUniversity of California San Francisco Medical CenterSan Francisco, California
Current Clinical Practice for Chemotherapy-Induced Nausea and Vomiting: Understanding the Up-to-Date Evidence-Based Guidelines for Prevention and Treatment
Una Hopkins, RN, DNPAssistant Professor, New York University NursingAdministrative Director, White Plains Hospital Cancer CenterWhite Plains, New York
Contributing Editorial Support
Anna Azyolinsky, PhDMedical ConsultantNew York, New York
Beatriz Manzor Mitrzyk, PharmD, BCPSMedical ConsultantNorthville, Michigan
Activity Overview
This activity is designed to educate oncologists and oncology nurses on the optimal management of chemotherapy-induced nausea and vomiting (CINV), education on the efficacy and safety data for current and emerging agents for the treatment of CINV, and current guidelines for management of CINV.
To continue this CME, click here.
Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander
October 31st 2024In this episode of Targeted Talks, Seth Wander, MD, PhD, discusses the clinical importance of ESR1 mutations in HR-positive metastatic breast cancer and how these mutations influence treatment approaches.
Listen
